SCHEMBL6115265

SCHEMBL6115265

CCCCCCCCCc1cccc2ncccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 8/20 0.51
CYP19A1 P11511 1/20 0.49
TBXAS1 P24557 1/20 0.49
TRPV1 Q8NER1 1/20 0.47
LIPG Q9Y5X9 1/20 0.45
KCNH2 Q12809 1/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
TLR7 Q9NYK1 1/20 0.44
CHRM1 P11229 1/20 0.43
S1PR2 O95136 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GLS O94925 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6114564 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6114918 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6115077 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6115015 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6114780 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6114419 1.00 TLR8 (0.51) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL4242510 0.98 TLR8 (0.50) TLR8CYP19A1TBXAS1TRPV1LIPG
SCHEMBL6115223 0.93 CYP19A1 (0.51) TLR8CYP19A1TBXAS1TRPV1KDM4E
SCHEMBL6114551 0.88 LOXL2 (0.53) TLR8LIPGKDM4EMAPTTLR7
SCHEMBL10585446 0.88 LOXL2 (0.53) TLR8LIPGKDM4EMAPTTLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104211620-B The autofrettage of bi-quaternary ammonium salt and its intermediate Wako-chem Industries Co., Ltd. (JP) 2016-05-25 CN disclosed
EP-2821395-A2 Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery Wako Pure Chemical Industries, Ltd. (JP) 2015-01-07 EP disclosed
CN-104211620-A PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEM IND LTD 2014-12-17 CN disclosed
US-8716513-B2 Process for production of bis-quaternary ammonium salt, and novel intermediate WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-06 US disclosed
EP-2463266-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
CN-102482197-A Process for producing diquaternary ammonium salt and novel intermediate WAKO PURE CHEM IND LTD 2012-05-30 CN disclosed
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130107-A1 PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE ASS1, C1S, FHIT TLR8 3836/4885CYP19A1 3096/4885TBXAS1 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.